脑部放疗，上午比下午敏感许多！, Y8 ?$ W0 L$ Y! J+ J) W1 k
0 s' N# _- Y, `: Z" K
0 y1 P' _; G5 X3 ?' H! x5 z5 ?Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.: t. \# `. Y+ A6 t
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
7 D* X% k/ H4 ` h e/ CRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
% {9 \8 y; Z! V. p$ l$ |SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.3 P. c0 k5 r3 J' C4 i+ L
& G& T1 {: ]+ F
Abstract' E$ ]- t" \+ ]8 o, @3 ^) ~
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
* }2 [ g+ M2 X# D) ]* {
3 q8 m# F. V, }3 ]- E- w- JMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
+ x) o% M3 A9 a+ v- S! j1 d5 @, D- f& \7 f9 L: C/ i. w$ b# |
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
# c. z+ F/ d* g: R; K7 z, p% }& ~" E7 P' R
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.( C- j, s( m( }4 q/ I% G/ z
; h: ?( p" i" z2 B
|
显身卡
